Trials / Unknown
UnknownNCT01634984
The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Selected 400 cases of women with primary breast cancer who were treated with operation randomly, then detect the expression of CDK5RAP2 of cancer tissue. At the same time randomly selected 100 women with primary breast cancer who were under neoadjuvant chemotherapy. Detect the expression of CDK5RAP2 before and after neoadjuvant chemotherapy.
Detailed description
The investigators selected 400 cases of women with primary breast cancer who were treated with operation randomly,then detect the expression of CDK5RAP2 of cancer tissue. At the same time randomly selected 100 women with primary breast cancer who were under neoadjuvant chemotherapy. Detect the expression of CDK5RAP2 before and after neoadjuvant chemotherapy.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2016-11-01
- Completion
- 2016-12-01
- First posted
- 2012-07-06
- Last updated
- 2015-12-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01634984. Inclusion in this directory is not an endorsement.